Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Pervin, Hurmuz"'
Autor:
Philip Sutera, MD, Matthew P. Deek, MD, Rebecca A. Deek, MS, Ozan Cem Guler, MD, Pervin Hurmuz, MD, Mehmet Reyhan, MD, Steven Rowe, MD, PhD, Noura Radwan, MD, Shirl Dipasquale, MSRN, William T. Hrinivich, PhD, Kathryn Lowe, MA, Lei Ren, PhD, Biren Saraiya, MD, Ronald Ennis, MD, Lara Hathout, MD, Tina Mayer, MD, Theodore L. Deweese, MD, Daniel Y. Song, MD, Ana Kiess, MD, Ezgi Oymak, MD, Kenneth Pienta, MD, Felix Feng, MD, Martin Pomper, MD, PhD, Gokhan Ozyigit, MD, Phuoc T. Tran, MD, PhD, Cem Onal, MD, Ryan M. Phillips, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 7, Pp 101507- (2024)
Purpose: Emerging data suggest that metastasis-directed therapy (MDT) improves outcomes in patients with oligometastatic castration-sensitive prostate cancer (omCSPC). Prostate-specific membrane antigen positron emission tomography (PSMA-PET) can det
Externí odkaz:
https://doaj.org/article/919f5deb98734f49825fc1c228a4a377
Autor:
Ozan Cem Guler, Ezgi Oymak, Pervin Hurmuz, Guler Yavas, Burak Tilki, Cagdas Yavas, Gokhan Ozyigit, Cem Onal
Publikováno v:
Urologia Internationalis. 107:171-178
Introduction: The aim of this study was to investigate the clinical outcomes of metastasis-directed therapy (MDT) using stereotactic body radiotherapy (SBRT) in patients with synchronous or metachronous oligometastatic renal cell carcinoma (RCC). Met
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-6 (2017)
Purpose: Complementary and alternative medicine (CAM) has been popular among patients with cancer for several decades. The objectives of this study were to evaluate the prevalence of CAM use and to identify the factors affecting CAM use in a large pa
Externí odkaz:
https://doaj.org/article/83290394b4794904818c8b5e0de582e2
Autor:
Pervin Hurmuz, Mustafa Cengiz, Gokhan Ozyigit, Sezin Yuce Sari, Alper Kahvecioglu, Caglayan Selenge Beduk Esen, Suayib Yalcin, Faruk Zorlu
Publikováno v:
Cureus.
Publikováno v:
Journal of Cancer Education. 38:426-430
Patients receiving stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) may have an anxiety due to unknown aspects of the treatment. We aimed to reduce patient anxiety by using video-based education. Forty patients were divi
Autor:
Cem Onal, Ezgi Oymak, Ozan Cem Guler, Burak Tilki, Guler Yavas, Pervin Hurmuz, Cagdas Yavas, Gokhan Ozyigit
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
Few studies have determined the viability of stereotactic body radiotherapy (SBRT) and tyrosine kinase inhibitors (TKIs) in the treatment of metastatic renal cell carcinoma (mRCC). We examined the results of RCC patients who had five or fewer lesions
Autor:
Ezgi Oymak, Cem Onal, Mehmet Reyhan, Ozan Cem Guler, Pervin Hurmuz, Murat Tuncel, Gokhan Ozyigit, Burak Tilki, Fadil Akyol
Publikováno v:
The Prostate. 81:648-656
Background Defining the extent of disease spread with imaging modalities is crucial for therapeutic decision-making and definition of treatment. This study aimed to investigate whether clinical parameters and nomograms predict prostate-specific membr
Publikováno v:
Lung Cancer. 179:107179
Autor:
Sadık Muallaoğlu, Cem Onal, Pervin Hurmuz, Fadil Akyol, Ezgi Oymak, Sercan Aksoy, Burak Tilki, Fatih Kose, Gokhan Ozyigit, Ozan Cem Guler
Publikováno v:
The Prostate. 81:543-552
Purpose/objective(s) Metastasis- directed therapy (MDT) utilizing stereotactic body radiotherapy (SBRT) for oligoprogressive lesions could provide a delay in next-line systemic treatment (NEST) change while undergoing androgen receptor-targeted agent
Autor:
Pervin Hurmuz
Publikováno v:
International Journal of Hematology and Oncology. 31:1-7